News

Open Text Puts MS Tech to Use for Lifesciences

At the 42nd Annual Drug Information Association (DIA) Meeting, Open Text, a provider of enterprise content management (ECM) software, announced that it is extending its use of Microsoft technology to encompass Open Text's solutions for Pharmaceuticals and Life Sciences. By integrating with the Microsoft platform, Open Text intends to help companies protect technology investments, and make enterprise content and compliance accessible to all company employees.

Building on the 2007 Microsoft Office system, Open Text is delivering a completely integrated content management technology and solutions set in the Pharmaceutical and Life Sciences industry. Open Text's Livelink ECM storage
and meta data services will extend the collaboration and Web content management features of Microsoft Office SharePoint Server 2007 to give companies a single platform to manage all enterprise content from creation to end of life.

Open Text will introduce its Regulated Documents solution for the Microsoft platform later this year. With this solution, Open Text expects that companies will be able to use Microsoft applications to manage, author, review and approve content in a controlled environment that is compliant with specific guidelines in the U.S. Food and Drug Administration's (FDA) 21 CFR Part 11 regulations, which address how information on new drug submissions must be managed and submitted
to the FDA.

"Our relationship with Open Text allows our customers to get more out of their investment in our platform and solutions," said Steve Shihadeh, General Manager, Healthcare and Life Sciences at Microsoft Corp.


print	save	email	comment